Maple Leaf Green World (TSXV:MGW; OTCQB:MGWFF) has received a distance separation analysis (DSA) from the City of Henderson with respect to Maple Leaf’s proposed site for a medical marijuana establishment-cultivation facility. The proposed site (see news release dated January 30, 2017) was reviewed by City of Henderson staff for compliance with the City of Henderson Title 19 – Medical Marijuana Establishment distance separation requirements as listed in Table 19.5.5-2 of the Henderson Development Code. Based on the findings in the DSA, the proposed site satisfies the minimum separation standards for protected uses and would be suitable for a Medical Marijuana Establishment – Cultivation Facility within the City’s boundaries. The proposed site meets the minimum buffer distance from protected uses as defined in NRS 453A and Chapter 19 of the City of Henderson Municipal Code.
The DSA is the most important step in transferring the existing cultivation permit held by BioNeva Innovations of Henderson, LLC (the “Permit”) to the proposed site. As the DSA has been completed, the next steps will require the Company to submit its building plans to the City of Henderson for approval of a Conditional Use Permit (“CUP”). If the Company is successful in obtaining a CUP, it can begin construction on the marijuana cultivation facility on the proposed site.
With the DSA in hand, the Company will now proceed to complete the purchase of the proposed site and to finalize its acquisition of the Permit, through the purchase of 100% of the shares of BioNeva.
“There are only 10 permitted cultivation facilities serving about 27 dispensaries and 6 production licensees in the City of Henderson. Maple Leaf is well on its way to becoming the 11th permitted cultivator in this area (not includes Las Vegas) and we believe attaining this status will add significant value to the Company” said Raymond Lai, President & C.E.O. of Maple Leaf.
Company’s 1st Shareholder Reception
Maple Leaf Green World held its first shareholder reception on the evening of February 4, 2017. The event was a great success, with over 150 people in attendance. The Company’s management team (including its project managers and chief growers from all three of its existing marijuana projects in Canada and the United States) was in attendance. The video of the event along with an interview with Bubba Kush will be available to view on our website on February 23, 2017.
About Maple Leaf Green World Inc.
Maple Leaf Green World Inc. is a public Canadian company that focuses on the cannabis industry in North America. With over 10 years of extensive greenhouse management experience, it applies its eco- agriculture knowledge and cultivation technology to produce contaminant -free organic cannabis products.
Maple Leaf’s long-term objective is to produce cannabis oil and export its products to approved countries.
Click here to connect with Maple Leaf Green World (TSXV:MGW; OTCQB:MGWFF) to receive an Investor Presentation.
The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.
Also this week, new data showed sales of Canadian cannabis edible products may be stalling.
The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.
Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.
Portnoy Law Firm: Credit Acceptance Corporation, Aurora Cannabis, Inc., and Loop Industries, Inc. Investors Have Limited Amount of Time Before Class Action Deadline
The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.
Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .
Khiron Plans to Launch Its Zerenia Medical Cannabis Clinic Strategy in Mexico; Applauds Mexican Senate Approval of Legislation for Cannabis in Mexico
- On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
- On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
- To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
- The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
- Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
- Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
- Company to release Q3 2020 financials and host webcast on Tuesday, December 1st
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products. Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.
BevCanna Provides Update on Commercialization Plans and Landmark Proposed Acquisition of Naturo Group
Recap of special management call includes upcoming corporate milestones and details of proposed combination with established beverage manufacturer
Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, OTCQB:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) is pleased to provide a recorded recap of the special management call held on Tuesday November 24, 2020. The call discussed upcoming corporate milestones and reviewed recent developments at the developer and manufacturer of cannabinoid‐infused beverages and consumer products for in‐house brands and white label clients.